Bank of America
KITE

Bank of America’s Kite Pharma, Inc. KITE Stock Holding History

Bank of America’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-35,900
Closed -$6.46M – 7513
2017
Q3 		$6.46M Buy
+35,900
New +$5M ﹤0.01% 2945

Bank of America's KITE Position: Q4 2017 in Review

Bank of America sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 154,316 shares — an estimated $27.7M sold.

Bank of America first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $27.7M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Bank of America reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Bank of America sold 154,316 Kite Pharma, Inc. shares in Q4 2017, an estimated $27.7M.
  • Bank of America first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
  • Bank of America's Kite Pharma, Inc. position peaked at $27.7M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Bank of America's 13F filing for Q4 2017, filed 14 Feb 2018.